Journal article · 2018 · Open access

Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare

Laura Amato, Simona Vecchi, Corrado Barbui, Fabio Cruciani, Roberto D’Amico, Cinzia Del Giovane, Silvia Minozzi, Zuzana Mitrova, Rosella Saulle, Marina Davoli

Recenti Progressi in Medicina, 109(10), 474–486 · Published 1 October 2018 · DOI 10.1701/3010.30085

Open full textView at the publisherCite this paper

In brief

“Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare” is a 2018 journal article by Laura Amato and 9 co-authors, published in Recenti Progressi in Medicina. OpenAlex counts 4 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at IRIS UNIMORE (University of Modena and Reggio Emilia).

Citations
4
Most cited in
2021 (2)
Field-weighted impact
0.29
Authors
10

Abstract

BACKGROUND: The World Health Organization (WHO) estimates that depression affects about 121 million people in the world and in terms of years of illness, by the year 2020 could become the second most prevalent disease in the world population after cardiovascular diseases. Second-generation antipsychotics (SGAs) seems to induce remission in depression when added to an antidepressant. AIM: To evaluate the efficacy and safety of SGAs for the treatment of depression. METHODS: We searched five bibliographic databases. We assessed the quality of evidence using Cochrane and GRADE criteria. RESULTS: We included 42 RCTs. Where possible, we made a statistical synthesis of results. For efficacy outcomes, in direct comparisons in unipolar and bipolar patients with acute depressive episode, and in unipolar patients who did not respond to previous treatments with antidepressants (non-responders), SGAs gave better results than placebo, moderate to low certainty of evidence. In the comparison with antidepressants, in unipolar and bipolar patients with acute depressive episode the evidence was in favour of SGAs high certainty of evidence; while in the non-responder unipolar patients (the included studies considered only this typology of patients) the evidence was in favour of the antidepressants, low certainty of evidence. For safety outcomes, the results were in favour of placebo for patients with at least one adverse event, and in favour of SGAs for the number of patients with serious adverse events, for both comparisons the certainty of evidence was moderate. Comparing the SGAs with antidepressants, no differences were observed for patients with at least one adverse event, high certainty of evidence; while serious adverse events were less acute in patients treated with SGAs, moderate certainty evidence. The results of direct and indirect comparisons made with the network meta-analysis showed no differences for most of the outcomes considered, not showing a clear superiority of a drug compared to the others. CONCLUSIONS: These results showed a moderate effect in favour of SGAs compared to antidepressants in patients, unipolar and bipolar, with a new acute depressive episode and confirm that in patients non-responders, antidepressants may remain more effective.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Amato, L., Vecchi, S., Barbui, C., Cruciani, F., D’Amico, R., Del Giovane, C., Minozzi, S., Mitrova, Z., Saulle, R., & Davoli, M. (2018). Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare. Recenti Progressi in Medicina, 109(10), 474–486. https://doi.org/10.1701/3010.30085

MLA 9

Amato, Laura, et al. “Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare.” Recenti Progressi in Medicina, vol. 109, no. 10, 2018, pp. 474–486. https://doi.org/10.1701/3010.30085.

Chicago

Amato, Laura, Simona Vecchi, Corrado Barbui, Fabio Cruciani, Roberto D’Amico, Cinzia Del Giovane, Silvia Minozzi, Zuzana Mitrova, Rosella Saulle, and Marina Davoli. 2018. “Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare.” Recenti Progressi in Medicina 109 (10): 474–486. https://doi.org/10.1701/3010.30085.

Harvard

Amato, L. et al. (2018) ‘Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare’, Recenti Progressi in Medicina, 109(10), pp. 474–486. doi:10.1701/3010.30085.

IEEE

L. Amato et al., “Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare,” Recenti Progressi in Medicina, vol. 109, no. 10, pp. 474–486, 2018, doi: 10.1701/3010.30085.

BibTeX

@article{amato2018revisione,
  title     = {{Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare}},
  author    = {Amato, Laura and Vecchi, Simona and Barbui, Corrado and Cruciani, Fabio and D’Amico, Roberto and Del Giovane, Cinzia and Minozzi, Silvia and Mitrova, Zuzana and Saulle, Rosella and Davoli, Marina},
  journal   = {Recenti Progressi in Medicina},
  year      = {2018},
  volume    = {109},
  number    = {10},
  pages     = {474--486},
  doi       = {10.1701/3010.30085},
  url       = {https://doi.org/10.1701/3010.30085}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202122
202211
202511

Its field-weighted citation impact is 0.29: it has been cited 0.29 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression

  • atypical antipsychotics
  • depression
  • bipolar depression
  • major depressive disorder
  • acute depressive episode
  • antidepressant non-responders
  • antidepressant augmentation
  • efficacy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Amato, L., Vecchi, S., Barbui, C., Cruciani, F., D’Amico, R., Del Giovane, C., Minozzi, S., Mitrova, Z., Saulle, R., & Davoli, M. (2018). Revisione sistematica per valutare l’efficacia, l’accettabilità e la sicurezza degli antipsicotici di seconda generazione per il trattamento della depressione unipolare e bipolare. Recenti Progressi in Medicina, 109(10), 474–486. https://doi.org/10.1701/3010.30085

How many times has this paper been cited?

4 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at IRIS UNIMORE (University of Modena and Reggio Emilia): sign in and open the full text from this page.

Who wrote this paper?

Laura Amato, Simona Vecchi, Corrado Barbui, Fabio Cruciani, Roberto D’Amico, Cinzia Del Giovane, Silvia Minozzi, Zuzana Mitrova, Rosella Saulle, Marina Davoli.

What is the DOI of this paper?

10.1701/3010.30085, permanently at https://doi.org/10.1701/3010.30085. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.